Breast Cancer News and Research

Latest Breast Cancer News and Research

Obese women more likely to have breast cancer at later stage: Study

Obese women are more likely to have breast cancer detected at a later stage and to have lymph node metastases when diagnosed than women who are not obese, according to a study presented this week at the Annual Meeting of the American Society of Breast Surgeons.

3 May 2010

Smoking can increase risk of second cancer in breast cancer survivors

Women who survive early-stage breast cancer and smoke have an increased chance of developing a new second cancer in their other breast or elsewhere.

3 May 2010

McGill scientist discovers how one particular gene regulates epithelial cells

New research led by McGill Biochemist Dr. William Muller helps explain why breast-milk cells lose their structure, causing them to clump up in strange ways (photos available) and sometimes become cancer tumors. With the support of Chen Ling and Dongmei Zuo at McGill's Goodman Cancer Centre, Muller has discovered how one particular gene regulates epithelial cells - cells that normally form in sheets and are polarized to enable the transport of molecules in a single direction.

30 Apr 2010

Leading experts deliver breast cancer updates at unique public forum

While significant advances have been made in breast cancer care, evidence has shown that Ontarians diagnosed with breast cancer continue to face considerable challenges with their needs for information, support and care. To respond to these needs, the Canadian Breast Cancer Foundation - Ontario Region is working with leaders in research, clinical care and community support to deliver current breast cancer information and education at a free public forum presented by Scotiabank Group in Barrie called Breast Cancer Today: An Evening of Care and Community.

30 Apr 2010

Update on BioSante cancer vaccine portfolio to be presented at BIO International Convention

BioSante Pharmaceuticals, Inc. will present a BioSante cancer vaccine portfolio update at the BIO International Convention, which will take place May 3-6 in Chicago, Illinois.

30 Apr 2010

HHS Secretary to host web chat to discuss impact of newly passed health insurance reform law

HHS Secretary Sebelius, Jay Angoff, director of the Office of Consumer Information and Insurance Oversight, and Keysha Brooks Coley, the director of Federal Relations with the American Cancer Society, will host a web chat Friday, April 30 to discuss important insurance reforms in the new legislation and recent developments that have led to the ending of controversial practices like rescissions.

30 Apr 2010

Jumping elements in primates may have important consequences for studies of human genetic diseases

The density of transposable (jumping) elements between sex chromosomes in primates may have important consequences for the studies of human genetic diseases, say Penn State University researchers.

30 Apr 2010

Study confirms MammaPrint's capabilities in determining patients likely to benefit from chemotherapy

Today, at the 11th Annual Meeting of the American Society of Breast Surgeons, Agendia, a world leader in molecular cancer diagnostics, announced that Breast Cancer Research and Treatment has published an important study demonstrating the benefit of adjuvant chemotherapy for patients with a high-risk of breast cancer recurrence according to the MammaPrint test. The ASBS meeting takes places April 28 - May 2, 2010, at the Bellagio in Las Vegas, where you can meet the Agendia team at booth # 314.

30 Apr 2010

Women with family history of breast cancer face increase risk of ovarian cancer

Ovarian cancer is the most deadly disease of the female reproductive system, with most cases diagnosed in later stages. Yet while ovarian cancer affects 1 in 70 women in the United States, many women have never discussed the risk with their doctor.

30 Apr 2010

Immunogen reports a net loss of $12.1 million in third quarter 2010

ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced financial results for the three-month period ended March 31, 2010 - the third quarter of the Company's 2010 fiscal year (3QFY10).

30 Apr 2010

Provectus reports on end-of-Phase 2 meeting with FDA on licensure of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has held an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) to seek consensus on clinical program scope and endpoints for licensure of PV-10 for metastatic melanoma. The meeting was held at the Agency's White Oak Campus in Silver Spring, MD.

29 Apr 2010

AVEO Pharmaceuticals reports net loss of $14.4 million for first-quarter 2010

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced financial results for the quarter ended March 31, 2010, provided an update on progress towards achievement of 2010 goals as well as 2010 financial guidance.

29 Apr 2010

Power3 Medical Products to present four abstracts at International Congress of Alzheimer's Disease

Power3 Medical Products, Inc. announced that four abstracts were accepted for presentation to the annual meeting of the International Congress of Alzheimer's Disease on July 12, 2010 in Honolulu, Hawaii. The presentations will cover results from protein biomarker discovery, drug response, test development, and ongoing clinical validation trials of the NuroPro AD biomarkers and blood test for Alzheimer's disease.

29 Apr 2010

HHS Secretary's statement on WellPoint's announcement to end practice of rescissions

U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius released the following statement today on WellPoint's announcement that it intends to end the practice of rescinding patients' coverage in advance of the Affordable Care Act's requirement that insurers stop this practice starting this fall. WellPoint's announcement comes after Secretary Sebelius sent a letter on April 22 urging the company to immediately stop the practice of rescinding coverage for patients who become ill.

29 Apr 2010

WellPoint profits rise 51 percent amid scrutiny on several fronts

WellPoint, the U.S. health insurer with the biggest membership, announced Wednesday that its first-quarter earnings rose 51 percent compared to last year and were boosted by a mild flu season, The Wall Street Journal reports. Medical membership fell 2.1% to 33.8 million as of March 31 from a year earlier but rose by 165,000 during the quarter. The company trimmed its year-end medical membership projection to 33.1 million from 33.3 million."

29 Apr 2010

Three new biomarkers for ductal carcinoma in situ found

A new study of women who have been diagnosed with ductal carcinoma in situ (D.C.I.S.), may help personalize cancer treatment required by the women.

29 Apr 2010

Imaging costs for Medicare cancer patients on the rise

A study in the Journal of the American Medical Association analyzed data from Medicare cancer patients to determine the change in imaging use for this group.

29 Apr 2010

Neoprobe reports revenues of $2.7M for first-quarter 2010

Neoprobe Corporation, a diversified developer of innovative biomedical surgical oncology products, today announced consolidated results for the first quarter of 2010. First quarter 2010 revenues were $2.7 million, consistent with the record revenue reported for the first quarter of 2009.

29 Apr 2010

After bad publicity, insurer to act early on ending practice of canceling policies of sick patients

WellPoint will put into effect this week a health overhaul provision preventing insurers from canceling policies -- a practice known as rescission -- except in fraud cases, even though the change isn't required until September, the Indianapolis Star reports.

28 Apr 2010

Wellstar International to install TMI Imaging system in Beverly Hills

Wellstar International Inc. has announced they will be installing a system in Beverly Hills, California.

28 Apr 2010

Breast Cancer News and Research

Latest Breast Cancer News and Research

Obese women more likely to have breast cancer at later stage: Study

Smoking can increase risk of second cancer in breast cancer survivors

McGill scientist discovers how one particular gene regulates epithelial cells

Leading experts deliver breast cancer updates at unique public forum

Update on BioSante cancer vaccine portfolio to be presented at BIO International Convention

HHS Secretary to host web chat to discuss impact of newly passed health insurance reform law

Jumping elements in primates may have important consequences for studies of human genetic diseases

Study confirms MammaPrint's capabilities in determining patients likely to benefit from chemotherapy

Women with family history of breast cancer face increase risk of ovarian cancer

Immunogen reports a net loss of $12.1 million in third quarter 2010

Provectus reports on end-of-Phase 2 meeting with FDA on licensure of PV-10 for metastatic melanoma

AVEO Pharmaceuticals reports net loss of $14.4 million for first-quarter 2010

Power3 Medical Products to present four abstracts at International Congress of Alzheimer's Disease

HHS Secretary's statement on WellPoint's announcement to end practice of rescissions

WellPoint profits rise 51 percent amid scrutiny on several fronts

Three new biomarkers for ductal carcinoma in situ found

Imaging costs for Medicare cancer patients on the rise

Neoprobe reports revenues of $2.7M for first-quarter 2010

After bad publicity, insurer to act early on ending practice of canceling policies of sick patients

Wellstar International to install TMI Imaging system in Beverly Hills

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in